Autosomal recessive primary microcephaly

disease
On this page

Also known as MCPHmicrocephalia veramicrocephaly veramicrocephaly, primary autosomal recessivemicrocephaly, primary, autosomal recessivetrue microcephaly

Summary

Autosomal recessive primary microcephaly (MONDO:0016660) is a disease (an umbrella term covering 29 Mondo subtypes) caused by variants in ASPM, KIF14, and STIL, with 27 cohort genes. The dominant Reactome pathway is Loss of Nlp from mitotic centrosomes (5 cohort genes).

At a glance

  • Prevalence: 1-9 / 1 000 000 (Specific population) [Orphanet-validated]
  • Causal genes: ASPM (GenCC Definitive), KIF14 (GenCC Definitive), STIL (GenCC Definitive)
  • Umbrella term: 29 Mondo subtypes
  • Cohort genes: 27
  • ClinVar variants: 45
  • Phenotypes (HPO): 17

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Annual incidence1-9 / 1 000 0000.1Specific populationValidated
Annual incidence1-9 / 100 0001PakistanValidated

Signs & symptoms

Clinical features (HPO)

17 HPO clinical features (Orphanet curated; top 17 by frequency):

HPO IDTermFrequency
HP:0000219Thin upper lip vermilionVery frequent (80-99%)
HP:0000252MicrocephalyVery frequent (80-99%)
HP:0000340Sloping foreheadVery frequent (80-99%)
HP:0000582Upslanted palpebral fissureVery frequent (80-99%)
HP:0001263Global developmental delayVery frequent (80-99%)
HP:0001510Growth delayVery frequent (80-99%)
HP:0002282Gray matter heterotopiaVery frequent (80-99%)
HP:0004322Short statureVery frequent (80-99%)
HP:0010864Intellectual disability, severeVery frequent (80-99%)
HP:0000076Vesicoureteral refluxFrequent (30-79%)
HP:0000122Unilateral renal agenesisFrequent (30-79%)
HP:0001274Agenesis of corpus callosumFrequent (30-79%)
HP:0001302PachygyriaFrequent (30-79%)
HP:0001347HyperreflexiaFrequent (30-79%)
HP:0002119VentriculomegalyFrequent (30-79%)
HP:0003103Abnormal cortical bone morphologyFrequent (30-79%)
HP:0007333Hypoplasia of the frontal lobesFrequent (30-79%)

Identifiers

Disease identifiers

FieldValue
Canonical nameautosomal recessive primary microcephaly
Mondo IDMONDO:0016660
MeSHC579935
OMIM251200
Orphanet2512
DOIDDOID:0070296
SNOMED CT715981004
UMLSC3711387
MedGen777995
GARD0012117
Is cancer (heuristic)no

Also known as: MCPH · microcephalia vera · microcephaly vera · microcephaly, primary autosomal recessive · microcephaly, primary, autosomal recessive · true microcephaly

Data availability: 45 ClinVar variants · 27 GenCC gene-disease records.

Disease family

An umbrella term covering 29 Mondo subtypes.

Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary disease › autosomal genetic disease › autosomal recessive diseaseautosomal recessive primary microcephaly

Related subtypes (218): immunodeficiency-centromeric instability-facial anomalies syndrome, hypercalcemia, infantile, Ochoa syndrome, autosomal recessive Ehlers-Danlos syndrome, vascular type, hydrolethalus syndrome, 3-M syndrome, isolated hyperchlorhidrosis, dacryocystitis-osteopoikilosis syndrome, Hutchinson-Gilford progeria syndrome, achalasia microcephaly syndrome, acrorenal syndrome, autosomal recessive, beta-ketothiolase deficiency, autosomal recessive Alport syndrome, Alstrom syndrome, microphthalmia with limb anomalies, camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Behr syndrome, bifid nose, autosomal recessive, Bloom syndrome, Bowen-Conradi syndrome, camptodactyly with fibrous tissue hyperplasia and skeletal dysplasia, heart defects-limb shortening syndrome, autosomal recessive palmoplantar keratoderma and congenital alopecia, COFS syndrome, craniometaphyseal dysplasia, autosomal recessive, Fraser syndrome, cystic fibrosis, polycystic lipomembranous osteodysplasia with sclerosing leukoencephaly, persistent hyperplastic primary vitreous, autosomal recessive, Donnai-Barrow syndrome, Schöpf-Schulz-Passarge syndrome, cleft lip/palate-ectodermal dysplasia syndrome, Ellis-van Creveld syndrome, Wolcott-Rallison syndrome, autosomal recessive faciodigitogenital syndrome, acromesomelic dysplasia 2B, brittle cornea syndrome, triple-A syndrome, autosomal recessive humeroradial synostosis, multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome, hydrocephalus, nonsyndromic, autosomal recessive 1, autosomal recessive hydrocephalus due to congenital stenosis of aqueduct of Sylvius, hypertelorism, microtia, facial clefting syndrome, hypoparathyroidism-retardation-dysmorphism syndrome, Vici syndrome, Johanson-Blizzard syndrome, autosomal recessive Kenny-Caffey syndrome, Papillon-Lefevre disease, Haim-Munk syndrome, Laurence-Moon syndrome, Donohue syndrome, lipase deficiency, combined, autosomal recessive familial Mediterranean fever, thiamine-responsive megaloblastic anemia syndrome, cartilage-hair hypoplasia, Nijmegen breakage syndrome, pseudo-TORCH syndrome, Galloway-Mowat syndrome, mulibrey nanism, myotonia congenita, autosomal recessive, Schwartz-Jampel syndrome, proteosome-associated autoinflammatory syndrome, Netherton syndrome, Niemann-Pick disease type A, oculodentodigital dysplasia, autosomal recessive, odonto-onycho-dermal dysplasia, autosomal recessive omodysplasia, osteoporosis-pseudoglioma syndrome, Shwachman-Diamond syndrome, phenylketonuria, Bjornstad syndrome, Laron syndrome, autosomal recessive polycystic kidney disease, autosomal recessive inherited pseudoxanthoma elasticum, autosomal recessive multiple pterygium syndrome, rapadilino syndrome, short-rib thoracic dysplasia 9 with or without polydactyly, autosomal recessive Robinow syndrome, Sjogren-Larsson syndrome, scapuloperoneal spinal muscular atrophy, autosomal recessive, spondyloepiphyseal dysplasia tarda, autosomal recessive, inherited threoninemia, Pendred syndrome, autosomal recessive spondylocostal dysostosis, Werner syndrome, ABCD syndrome, Naxos disease, autosomal recessive amelia, human HOXA1 syndromes, sickle cell disease, autosomal recessive proximal renal tubular acidosis, hyper-IgM syndrome type 2, temtamy preaxial brachydactyly syndrome, TH-deficient dopa-responsive dystonia, craniosynostosis syndrome, autosomal recessive, Niemann-Pick disease type B, skin fragility-woolly hair-palmoplantar keratoderma syndrome, CoQ-responsive OXPHOS deficiency, familial adenomatous polyposis 2, Pierson syndrome, palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome, cardiomyopathy-hypotonia-lactic acidosis syndrome, PHARC syndrome, Kahrizi syndrome, cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies, congenital prothrombin deficiency, immunodeficiency 31B, dyskeratosis congenita, autosomal recessive 2, dyskeratosis congenita, autosomal recessive 3, Nestor-Guillermo progeria syndrome, leukoencephalopathy with calcifications and cysts, mitochondrial pyruvate carrier deficiency, branched-chain keto acid dehydrogenase kinase deficiency, dyskeratosis congenita, autosomal recessive 5, hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome, alacrima, achalasia, and intellectual disability syndrome, hyperlipoproteinemia, type 1D, microcephaly and chorioretinopathy 2, congenital stationary night blindness 1G, combined oxidative phosphorylation deficiency 29, hypermanganesemia with dystonia 2, growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy, gnb5-related intellectual disability-cardiac arrhythmia syndrome, autosomal recessive spastic paraplegia type 78, autosomal recessive limb-girdle muscular dystrophy, Bardet-Biedl syndrome, autosomal recessive cerebellar ataxia, neuronopathy, distal hereditary motor, autosomal recessive, UV-sensitive syndrome, Ehlers-Danlos syndrome, kyphoscoliotic type 1, Cockayne syndrome, hyperphenylalaninemia due to tetrahydrobiopterin deficiency, leukoencephalopathy-palmoplantar keratoderma syndrome, autosomal recessive hypohidrotic ectodermal dysplasia, Warburg micro syndrome, autosomal recessive progressive external ophthalmoplegia, Meier-Gorlin syndrome, autosomal recessive sideroblastic anemia, autosomal recessive intermediate Charcot-Marie-Tooth disease, Perrault syndrome, autosomal recessive hypophosphatemic rickets, de Barsy syndrome, leukocyte adhesion deficiency, Senior-Loken syndrome, autosomal recessive spastic ataxia, childhood-onset autosomal recessive myopathy with external ophthalmoplegia, autosomal recessive cerebral atrophy, GM3 synthase deficiency, autosomal recessive distal renal tubular acidosis, pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome, autosomal recessive brachyolmia, Aicardi-Goutieres syndrome, homocystinuria without methylmalonic aciduria, Niemann-Pick disease type C, nephronophthisis, autosomal recessive osteopetrosis, peroxisome biogenesis disorder, congenital non-bullous ichthyosiform erythroderma, Seckel syndrome, Usher syndrome, autosomal recessive cutis laxa type 1, autosomal recessive cutis laxa type 2, hearing loss, autosomal recessive, microcephaly, growth restriction, and increased sister chromatid exchange 2, encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1, congenital vertebral-cardiac-renal anomalies syndrome, hair defect with photosensitivity and intellectual disability syndrome, autosomal recessive severe congenital neutropenia, severe combined immunodeficiency due to CARMIL2 deficiency, extraoral halitosis due to methanethiol oxidase deficiency, neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities, mitochondrial complex 2 deficiency, nuclear type 3, mitochondrial complex 2 deficiency, nuclear type 4, mismatch repair cancer syndrome, spondyloepimetaphyseal dysplasia with joint laxity, type 3, Kilquist syndrome, Duane anomaly-myopathy-scoliosis syndrome, autosomal recessive axonal charcot-marie-tooth disease due to copper metabolism defect, immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome, optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome, congenital myopathy with reduced type 2 muscle fibers, NAD(P)HX dehydratase deficiency, autosomal recessive ocular albinism, ichthyosis linearis circumflexa, eosinophil peroxidase deficiency, hyperphenylalaninemia due to DNAJC12 deficiency, autosomal recessive epidermolytic ichthyosis, Ehlers-Danlos syndrome, classic-like, 2, joint laxity, short stature, and myopia, HELIX syndrome, auditory neuropathy-optic atrophy syndrome, glycosylphosphatidylinositol biosynthesis defect 15, neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures, SCN4A-related myopathy, autosomal recessive, Uner Tan Syndrome, nephropathic cystinosis, Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome type 2, permanent neonatal diabetes mellitus 1, growth hormone insensitivity with immune dysregulation 1, autosomal recessive, Rajab interstitial lung disease with brain calcifications 1, Roberts-SC phocomelia syndrome, neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities, RPE65-related recessive retinopathy, GUCY2D-related recessive retinopathy, autosomal recessive titinopathy, intellectual disability, autosomal recessive, ALPL-related autosomal recessive hypophosphatasia, spastic paraplegia 18b, autosomal recessive, CEP164-related ciliopathy, RP1-related recessive retinopathy, pseudohypoaldosteronism, type IB2, autosomal recessive, pseudohypoaldosteronism, type IB3, autosomal recessive, spastic paraplegia 30B, autosomal recessive, cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 1, brain small vessel disease 2B, autosomal recessive, IMPG1-related recessive retinopathy, PROM1-related recessive retinopathy

Subtypes (29): microcephaly 1, primary, autosomal recessive, microcephaly with simplified gyral pattern, microcephaly 2, primary, autosomal recessive, with or without cortical malformations, microcephaly 4, primary, autosomal recessive, microcephaly 3, primary, autosomal recessive, microcephaly 5, primary, autosomal recessive, microcephaly 7, primary, autosomal recessive, microcephaly 8, primary, autosomal recessive, microcephaly 9, primary, autosomal recessive, microcephalic primordial dwarfism due to ZNF335 deficiency, microcephaly 11, primary, autosomal recessive, microcephaly 13, primary, autosomal recessive, microcephaly 12, primary, autosomal recessive, microcephaly 14, primary, autosomal recessive, microcephaly 15, primary, autosomal recessive, microcephaly 16, primary, autosomal recessive, microcephaly 17, primary, autosomal recessive, microcephaly 28, primary, autosomal recessive, microcephaly 29, primary, autosomal recessive, microcephaly 24, primary, autosomal recessive, microcephaly 25, primary, autosomal recessive, microcephaly 19, primary, autosomal recessive, microcephaly 20, primary, autosomal recessive, microcephaly 21, primary, autosomal recessive, microcephaly 22, primary, autosomal recessive, microcephaly 23, primary, autosomal recessive, microcephaly with or without short stature, microcephaly 30, primary, autosomal recessive, microcephaly 31, primary, autosomal recessive

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

ClinVar germline variants

45 retrieved; paginated sample, class counts are floors:

25 pathogenic, 9 likely pathogenic, 5 pathogenic/likely pathogenic, 3 uncertain significance, 3 conflicting classifications of pathogenicity

ClinVarVariant (HGVS)GeneClassificationReview
4688532NC_000008.10:g.(6264211_6266799)_(6357451_6478974)delANGPT2Pathogeniccriteria provided, single submitter
4688536NC_000008.10:g.(?6264147)(6357451_6478974)delANGPT2Pathogeniccriteria provided, single submitter
157795NM_018136.5(ASPM):c.2419+2T>CASPMPathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
157867NM_018136.5(ASPM):c.7160_7161del (p.Ser2387fs)ASPMPathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
21582NM_018136.5(ASPM):c.3796G>T (p.Glu1266Ter)ASPMPathogeniccriteria provided, multiple submitters, no conflicts
2581671NM_018136.5(ASPM):c.8195_8196del (p.Arg2732fs)ASPMPathogeniccriteria provided, single submitter
3384969NM_018136.5(ASPM):c.6107_6110del (p.Val2036fs)ASPMPathogeniccriteria provided, single submitter
3600659NM_018136.5(ASPM):c.5505del (p.Phe1835fs)ASPMPathogeniccriteria provided, multiple submitters, no conflicts
3902244NM_018136.5(ASPM):c.3483_3484del (p.Ile1161fs)ASPMPathogeniccriteria provided, single submitter
3902257NM_018136.5(ASPM):c.1480del (p.Ser494fs)ASPMPathogeniccriteria provided, single submitter
432552NM_018136.5(ASPM):c.1697C>A (p.Ser566Ter)ASPMPathogeniccriteria provided, multiple submitters, no conflicts
4687500NM_018136.5(ASPM):c.4598_4601del (p.Asn1533fs)ASPMPathogeniccriteria provided, single submitter
4960NM_018136.5(ASPM):c.9178C>T (p.Gln3060Ter)ASPMPathogeniccriteria provided, multiple submitters, no conflicts
631585NM_018136.5(ASPM):c.4849C>T (p.Arg1617Ter)ASPMPathogeniccriteria provided, multiple submitters, no conflicts
252992NM_001206999.2(CIT):c.1111+1G>ACITPathogeniccriteria provided, single submitter
252993NM_001206999.2(CIT):c.412C>T (p.Gln138Ter)CITPathogenicno assertion criteria provided
252994NM_001206999.2(CIT):c.473C>G (p.Pro158Arg)CITPathogenicno assertion criteria provided
210670NM_018451.5(CPAP):c.898_899del (p.Glu300fs)CPAPPathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
158830NM_024596.5(MCPH1):c.1869_1870del (p.Ser623_Cys624insTer)MCPH1Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
2691298NM_024596.5(MCPH1):c.698C>A (p.Ser233Ter)MCPH1Pathogeniccriteria provided, multiple submitters, no conflicts
2826934NM_024596.5(MCPH1):c.595C>T (p.Gln199Ter)MCPH1Pathogeniccriteria provided, multiple submitters, no conflicts
30641NM_024596.5(MCPH1):c.215C>T (p.Ser72Leu)MCPH1Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
3902579NM_024596.5(MCPH1):c.2312del (p.Pro771fs)MCPH1Pathogeniccriteria provided, single submitter
4847425NM_024596.5(MCPH1):c.2021C>G (p.Ser674Ter)MCPH1Pathogeniccriteria provided, single submitter
4847982NC_000008.10:g.(?6264147)(6293684_6296473)delMCPH1Pathogeniccriteria provided, single submitter
4848157NM_024596.5(MCPH1):c.1341_1344del (p.Ser448fs)MCPH1Pathogeniccriteria provided, single submitter
2581189NM_024596.5(MCPH1):c.2404G>T (p.Gly802Ter)MCPH1-AS1Pathogeniccriteria provided, single submitter
31037NM_001083961.2(WDR62):c.1531G>A (p.Asp511Asn)WDR62Pathogeniccriteria provided, multiple submitters, no conflicts
3336245NC_000019.9:g.(36564434_36572334)_(36575647_36577588)delWDR62Pathogeniccriteria provided, single submitter
3896394NC_000019.9:g.(36550933_36556859)_(36564434_36572334)delWDR62Pathogeniccriteria provided, single submitter

Genes & proteins

Mendelian disease overlap and somatic drivers

GenCC: 108 · Orphanet: 35 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0

GenCC gene–disease validity (cohort genes)

the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.

GeneClassificationInheritanceDiseaseRecords
ASPMDefinitiveAutosomal recessiveautosomal recessive primary microcephaly5
CPAPDefinitiveAutosomal recessivemicrocephaly 6 with or without short stature5
KIF14DefinitiveAutosomal recessiveautosomal recessive primary microcephaly7
MCPH1DefinitiveAutosomal recessivemicrocephaly 1, primary, autosomal recessive6
MFSD2ADefinitiveAutosomal recessivemicrocephaly 15, primary, autosomal recessive4
STILDefinitiveAutosomal recessiveautosomal recessive primary microcephaly6
WDR62DefinitiveAutosomal recessivemicrocephaly 2, primary, autosomal recessive, with or without cortical malformations8
ANKLE2StrongAutosomal recessivemicrocephaly 16, primary, autosomal recessive4
CDK5RAP2StrongAutosomal recessivemicrocephaly 3, primary, autosomal recessive5
CEP135StrongAutosomal recessivemicrocephaly 8, primary, autosomal recessive3
CEP152StrongAutosomal recessivemicrocephaly 9, primary, autosomal recessive4
CITStrongAutosomal recessivemicrocephaly 17, primary, autosomal recessive4
KNL1StrongAutosomal recessivemicrocephaly 4, primary, autosomal recessive4
SASS6StrongAutosomal recessivemicrocephaly 14, primary, autosomal recessive5
NCAPD3ModerateAutosomal recessivemicrocephaly 22, primary, autosomal recessive3
PHC1ModerateAutosomal recessivemicrocephaly 11, primary, autosomal recessive4
CDK6SupportiveAutosomal recessiveautosomal recessive primary microcephaly2
CEP63SupportiveAutosomal recessiveautosomal recessive primary microcephaly4
COPB2SupportiveAutosomal recessiveautosomal recessive primary microcephaly7
METTL5SupportiveAutosomal recessiveautosomal recessive primary microcephaly5
PYCR2SupportiveAutosomal recessiveautosomal recessive primary microcephaly5
TAF13SupportiveAutosomal recessiveautosomal recessive primary microcephaly5
TRAPPC14SupportiveAutosomal recessiveautosomal recessive primary microcephaly
TEDC1LimitedAutosomal recessivemicrocephaly2

Orphanet rare-disease linkage (cohort genes)

GeneOrphanet IDRare disease
TAF13Orphanet:2512Autosomal recessive primary microcephaly
CPAPOrphanet:2512Autosomal recessive primary microcephaly
CPAPOrphanet:808Seckel syndrome
ASPMOrphanet:2512Autosomal recessive primary microcephaly
CITOrphanet:2512Autosomal recessive primary microcephaly
WDR62Orphanet:2512Autosomal recessive primary microcephaly
MCPH1Orphanet:2512Autosomal recessive primary microcephaly
STILOrphanet:220386Semilobar holoprosencephaly
STILOrphanet:2512Autosomal recessive primary microcephaly
STILOrphanet:280195Septopreoptic holoprosencephaly
STILOrphanet:93924Lobar holoprosencephaly
STILOrphanet:93925Alobar holoprosencephaly
STILOrphanet:93926Midline interhemispheric variant of holoprosencephaly
STILOrphanet:99861Precursor T-cell acute lymphoblastic leukemia
CDK6Orphanet:2512Autosomal recessive primary microcephaly
CDK5RAP2Orphanet:2512Autosomal recessive primary microcephaly
KIF14Orphanet:2512Autosomal recessive primary microcephaly
KIF14Orphanet:439897Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome
COPB2Orphanet:2512Autosomal recessive primary microcephaly
KNL1Orphanet:2512Autosomal recessive primary microcephaly
METTL5Orphanet:2512Autosomal recessive primary microcephaly
SASS6Orphanet:2512Autosomal recessive primary microcephaly
TRAPPC14Orphanet:2512Autosomal recessive primary microcephaly
CEP63Orphanet:808Seckel syndrome
MFSD2AOrphanet:2512Autosomal recessive primary microcephaly
NCAPD3Orphanet:2512Autosomal recessive primary microcephaly
CEP135Orphanet:2512Autosomal recessive primary microcephaly
ANKLE2Orphanet:2512Autosomal recessive primary microcephaly
CEP152Orphanet:2512Autosomal recessive primary microcephaly
CEP152Orphanet:808Seckel syndrome
PYCR2Orphanet:2512Autosomal recessive primary microcephaly
PYCR2Orphanet:481152PYCR2-related microcephaly-progressive leukoencephalopathy
PHC1Orphanet:2512Autosomal recessive primary microcephaly
ZNF335Orphanet:329228Microcephalic primordial dwarfism due to ZNF335 deficiency
ANGPT2Orphanet:363999Non-immune hydrops fetalis

Cohort genes → proteins

27 cohort genes, 26 distinct canonical proteins.

Evidence partition

SubsetGenes
multi_evidence27

Cohort genes (full)

SymbolHGNCEnsemblUniProtNameEvidence
TAF13HGNC:11546ENSG00000197780Q15543Transcription initiation factor TFIID subunit 13gencc,clinvar
CPAPHGNC:17272ENSG00000151849Q9HC77Centrosomal P4.1-associated proteingencc,clinvar
ASPMHGNC:19048ENSG00000066279Q8IZT6Abnormal spindle-like microcephaly-associated proteingencc,clinvar
CITHGNC:1985ENSG00000122966O14578Citron Rho-interacting kinasegencc,clinvar
WDR62HGNC:24502ENSG00000075702O43379WD repeat-containing protein 62gencc,clinvar
MCPH1HGNC:6954ENSG00000147316Q8NEM0Microcephalingencc,clinvar
STILHGNC:10879ENSG00000123473Q15468SCL-interrupting locus proteingencc
CDK6HGNC:1777ENSG00000105810Q00534Cyclin-dependent kinase 6gencc
CDK5RAP2HGNC:18672ENSG00000136861Q96SN8CDK5 regulatory subunit-associated protein 2gencc
KIF14HGNC:19181ENSG00000118193Q15058Kinesin-like protein KIF14gencc
TEDC1HGNC:20127ENSG00000185347Q86SX3Tubulin epsilon and delta complex protein 1gencc
COPB2HGNC:2232ENSG00000184432P35606Coatomer subunit beta'gencc
KNL1HGNC:24054ENSG00000137812Q8NG31Outer kinetochore KNL1 complex subunit KNL1gencc
METTL5HGNC:25006ENSG00000138382Q9NRN9rRNA N(6)-adenosine-methyltransferase METTL5gencc
SASS6HGNC:25403ENSG00000156876Q6UVJ0Spindle assembly abnormal protein 6 homologgencc
TRAPPC14HGNC:25604ENSG00000146826Q8WVR3Trafficking protein particle complex subunit 14gencc
CEP63HGNC:25815ENSG00000182923Q96MT8Centrosomal protein of 63 kDagencc
MFSD2AHGNC:25897ENSG00000168389Q8NA29Sodium-dependent lysophosphatidylcholine symporter 1gencc
NCAPD3HGNC:28952ENSG00000151503P42695Condensin-2 complex subunit D3gencc
CEP135HGNC:29086ENSG00000174799Q66GS9Centrosomal protein of 135 kDagencc
ANKLE2HGNC:29101ENSG00000176915Q86XL3Ankyrin repeat and LEM domain-containing protein 2gencc
CEP152HGNC:29298ENSG00000103995O94986Centrosomal protein of 152 kDagencc
PYCR2HGNC:30262ENSG00000143811Q96C36Pyrroline-5-carboxylate reductase 2gencc
PHC1HGNC:3182ENSG00000111752P78364Polyhomeotic-like protein 1gencc
ZNF335HGNC:15807ENSG00000198026Q9H4Z2Zinc finger protein 335clinvar
ANGPT2HGNC:485ENSG00000091879O15123Angiopoietin-2clinvar
MCPH1-AS1HGNC:51655ENSG00000249898MCPH1 antisense RNA 1clinvar

Cohort function summary

Lead sentence per gene, UniProt-curated.

SymbolProtein nameFunction (lead sentence)
TAF13Transcription initiation factor TFIID subunit 13The TFIID basal transcription factor complex plays a major role in the initiation of RNA polymerase II (Pol II)-dependent transcription.
CPAPCentrosomal P4.1-associated proteinPlays an important role in cell division and centrosome function by participating in centriole duplication.
ASPMAbnormal spindle-like microcephaly-associated proteinInvolved in mitotic spindle regulation and coordination of mitotic processes.
CITCitron Rho-interacting kinasePlays a role in cytokinesis.
WDR62WD repeat-containing protein 62Required for cerebral cortical development.
MCPH1MicrocephalinImplicated in chromosome condensation and DNA damage induced cellular responses.
STILSCL-interrupting locus proteinImmediate-early gene.
CDK6Cyclin-dependent kinase 6Serine/threonine-protein kinase involved in the control of the cell cycle and differentiation; promotes G1/S transition.
CDK5RAP2CDK5 regulatory subunit-associated protein 2Potential regulator of CDK5 activity via its interaction with CDK5R1.
KIF14Kinesin-like protein KIF14Microtubule motor protein that binds to microtubules with high affinity through each tubulin heterodimer and has an ATPase activity.
TEDC1Tubulin epsilon and delta complex protein 1Acts as a positive regulator of ciliary hedgehog signaling.
COPB2Coatomer subunit beta'The coatomer is a cytosolic protein complex that binds to dilysine motifs and reversibly associates with Golgi non-clathrin-coated vesicles, which further mediate biosynthetic protein transport from the ER, via the Golgi up to the trans Go…
KNL1Outer kinetochore KNL1 complex subunit KNL1Acts as a component of the outer kinetochore KNL1 complex that serves as a docking point for spindle assembly checkpoint components and mediates microtubule-kinetochore interactions.
METTL5rRNA N(6)-adenosine-methyltransferase METTL5Catalytic subunit of a heterodimer with TRMT112, which specifically methylates the 6th position of adenine in position 1832 of 18S rRNA.
SASS6Spindle assembly abnormal protein 6 homologCentral scaffolding component of the centrioles ensuring their 9-fold symmetry.
TRAPPC14Trafficking protein particle complex subunit 14Specific subunit of the TRAPP (transport protein particle) II complex, a highly conserved vesicle tethering complex that functions in late Golgi trafficking as a membrane tether.
CEP63Centrosomal protein of 63 kDaRequired for normal spindle assembly.
MFSD2ASodium-dependent lysophosphatidylcholine symporter 1Sodium-dependent lysophosphatidylcholine (LPC) symporter, which plays an essential role for blood-brain barrier formation and function.
NCAPD3Condensin-2 complex subunit D3Regulatory subunit of the condensin-2 complex, a complex which establishes mitotic chromosome architecture and is involved in physical rigidity of the chromatid axis.
CEP135Centrosomal protein of 135 kDaCentrosomal microtubule-binding protein involved in centriole biogenesis.
ANKLE2Ankyrin repeat and LEM domain-containing protein 2Involved in mitotic nuclear envelope reassembly by promoting dephosphorylation of BAF/BANF1 during mitotic exit.
CEP152Centrosomal protein of 152 kDaNecessary for centrosome duplication; the function also seems to involve CEP63, CDK5RAP2 and WDR62 through a stepwise assembled complex at the centrosome that recruits CDK2 required for centriole duplication.
PYCR2Pyrroline-5-carboxylate reductase 2Oxidoreductase that catalyzes the last step in proline biosynthesis, which corresponds to the reduction of pyrroline-5-carboxylate to L-proline using NAD(P)H.
PHC1Polyhomeotic-like protein 1Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development.
ZNF335Zinc finger protein 335Component or associated component of some histone methyltransferase complexes may regulate transcription through recruitment of those complexes on gene promoters.
ANGPT2Angiopoietin-2Binds to TEK/TIE2, competing for the ANGPT1 binding site, and modulating ANGPT1 signaling.

Protein-family classification

Druggable: 4 · Difficult: 5 · Unknown: 18 · Druggable fraction: 0.15

Family distribution

Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.

FamilyGenesFoldFDR
Transporter12.9×0.442
Kinase22.0×0.442
Scaffold/PPI31.9×0.442
Other/Unknown181.2×0.442
Antibody/Immunoglobulin11.1×0.732
Transcription factor20.6×0.856

Per-gene assignment

SymbolFamilyDruggable?ECInterPro (top 3)
TAF13Other/UnknownnoTFIID_TAF13, Histone-fold
CPAPOther/UnknownnoCENPJ_C_dom, TCP10L/CENPJ, Tcp10_C_sf
ASPMAntibody/ImmunoglobulinyesIQ_motif_EF-hand-BS, CH_dom, ARM-like
CITKinaseyesProt_kinase_dom, AGC-kinase_C, CNH_dom
WDR62Scaffold/PPInoWD40_rpt, Quinoprotein_ADH-like_sf, WD40/YVTN_repeat-like_dom_sf
MCPH1Other/UnknownnoBRCT_dom, Microcephalin-like, Microcephalin_mammal
STILOther/UnknownnoSTIL, STIL_CC, STIL_N
CDK6Kinaseyes2.7.11.22Prot_kinase_dom, Ser/Thr_kinase_AS, Kinase-like_dom_sf
CDK5RAP2Other/UnknownnoCnn_1N, CDK5RAP2, CDK5RAP2_MYOME_CC
KIF14Other/UnknownnoFHA_dom, Kinesin_motor_dom, SMAD_FHA_dom_sf
TEDC1Other/UnknownnoTEDC1_dom, TEDC1
COPB2Scaffold/PPInoWD40_rpt, Beta-prop_COPA/B_2nd, WD40/YVTN_repeat-like_dom_sf
KNL1Other/UnknownnoBlinkin, Knl1_RWD_C, KNL1_MELT_rpt
METTL5Other/UnknownnoDNA_methylase_N6_adenine_CS, Small_mtfrase_dom, SAM-dependent_MTases_sf
SASS6Other/UnknownnoSAS-6_N, SAS-6_N_sf, SAS6_CC
TRAPPC14Other/UnknownnoTRAPPC14, TRAPP14_C, TRAPP14_N
CEP63Other/UnknownnoCEP63/Deup1_N, CEP63/Deup1_CC
MFSD2ATransporteryesMFS_trans_sf, MFS_2
NCAPD3Other/UnknownnoARM-like, NCAPD3, ARM-type_fold
CEP135Other/UnknownnoCentriole_BasalBody_StrucProt
ANKLE2Scaffold/PPInoAnkyrin_rpt, LEM_dom, LEM/LEM-like_dom_sf
CEP152Other/UnknownnoCEP152/SHC-Transforming, CEP152_CC, CEP152_PLK4_bind
PYCR2Other/UnknownnoPyrroline-COOH_reductase, 6-PGluconate_DH-like_C_sf, P5C_Rdtase_cat_N
PHC1Transcription factornoSAM, Znf_FCS, SAM/pointed_sf
ZNF335Transcription factornoZnf_C2H2_type, Znf_C2H2_sf, Zinc_finger/UBP_domain
ANGPT2Other/UnknownnoFibrinogen_a/b/g_C_dom, Fibrinogen_a/b/g_C_1, Fibrinogen_CS
MCPH1-AS1Other/Unknownno

Expression context

Cohort genes with no expression data: 0.

24 cohort genes are a single-cell marker in ≥1 SCXA experiment.

Breadth distribution (Bgee present_calls)

BucketGenes
narrow (1-5 tissues)0
moderate (6-20)0
broad (>20)27
unknown0

Top tissues across cohort

TissueCohort genes
secondary oocyte8
oocyte5
ventricular zone4
sperm3
sural nerve3
right testis3
granulocyte3
lateral nuclear group of thalamus2
left testis2
calcaneal tendon2
primordial germ cell in gonad2
trabecular bone tissue2
mucosa of transverse colon2
tendon of biceps brachii2
parotid gland2
stromal cell of endometrium2
male germ line stem cell (sensu Vertebrata) in testis2
buccal mucosa cell2
right uterine tube2
gingival epithelium1

Per-gene tissue summary (top 30)

SymbolBgee breadthFANTOM5 breadthSCXATop tissues
TAF13270ubiquitousmarkermedial globus pallidus, lateral nuclear group of thalamus, gingival epithelium
CPAP246ubiquitousmarkersperm, left lobe of thyroid gland, right lobe of thyroid gland
ASPM176ubiquitousmarkeroocyte, ventricular zone, secondary oocyte
CIT232ubiquitousmarkerlateral nuclear group of thalamus, right frontal lobe, sural nerve
WDR62211ubiquitousmarkerleft testis, right testis, testis
MCPH1204ubiquitousmarkersecondary oocyte, ganglionic eminence, calcaneal tendon
STIL221ubiquitousmarkersecondary oocyte, oocyte, primordial germ cell in gonad
CDK6262ubiquitousmarkeradrenal tissue, trabecular bone tissue, pylorus
CDK5RAP2272ubiquitousmarkersural nerve, ventricular zone, right coronary artery
KIF14144ubiquitousmarkersecondary oocyte, endometrium epithelium, trabecular bone tissue
TEDC1169ubiquitousyestendon of biceps brachii, granulocyte, mucosa of transverse colon
COPB2295ubiquitousmarkerparotid gland, stromal cell of endometrium, type B pancreatic cell
KNL1193ubiquitousmarkermale germ line stem cell (sensu Vertebrata) in testis, ventricular zone, primordial germ cell in gonad
METTL5292ubiquitousmarkerparotid gland, skeletal muscle tissue of biceps brachii, biceps brachii
SASS6178ubiquitousmarkeroocyte, secondary oocyte, male germ line stem cell (sensu Vertebrata) in testis
TRAPPC14262ubiquitousyesmucosa of transverse colon, granulocyte, right testis
CEP63282ubiquitousmarkercalcaneal tendon, colonic epithelium, cortical plate
MFSD2A220ubiquitousmarkerright lobe of liver, skin of abdomen, ileal mucosa
NCAPD3226ubiquitousmarkersural nerve, secondary oocyte, ventricular zone
CEP135238ubiquitousmarkeramniotic fluid, buccal mucosa cell, sperm
ANKLE2289ubiquitousmarkerstromal cell of endometrium, left testis, right testis
CEP152218ubiquitousmarkersecondary oocyte, oocyte, sperm
PYCR2251ubiquitousmarkercardiac muscle of right atrium, right uterine tube, left ventricle myocardium
PHC1252ubiquitousmarkerright uterine tube, adenohypophysis, pituitary gland
ZNF335199ubiquitousmarkergranulocyte, right hemisphere of cerebellum, cerebellar hemisphere
ANGPT2219broadmarkertendon of biceps brachii, popliteal artery, tibial artery
MCPH1-AS1167ubiquitousyesbuccal mucosa cell, oocyte, secondary oocyte

Protein interactions among cohort

Intra-cohort edges: 79.

Hub genes (top 10 by interactor count)

SymbolInteractor count
KIF146,868
CDK66,767
CIT5,077
KNL13,438
COPB22,982
ASPM2,949
SASS62,336
CPAP2,242
CEP1352,226
NCAPD32,202

Intra-cohort edges

ABSources
ANKLE2CEP135string_interaction
ANKLE2CEP152string_interaction
ANKLE2CPAPstring_interaction
ANKLE2MCPH1string_interaction
ANKLE2MFSD2Astring_interaction
ANKLE2SASS6string_interaction
ANKLE2TRAPPC14string_interaction
ANKLE2WDR62string_interaction
ANKLE2ZNF335string_interaction
ASPMCDK5RAP2string_interaction
ASPMCEP152string_interaction
ASPMCEP63string_interaction
ASPMCITstring_interaction
ASPMCPAPstring_interaction
ASPMKIF14string_interaction
ASPMMCPH1string_interaction
ASPMSTILstring_interaction
ASPMWDR62string_interaction
ASPMZNF335string_interaction
CDK5RAP2CEP135string_interaction
CDK5RAP2CEP152biogrid_interaction, intact, string_interaction
CDK5RAP2CEP63string_interaction
CDK5RAP2CPAPstring_interaction
CDK5RAP2MCPH1string_interaction
CDK5RAP2STILstring_interaction
CDK5RAP2WDR62string_interaction
CDK5RAP2ZNF335string_interaction
CDK6ZNF335intact
CEP135CEP152string_interaction
CEP135CEP63string_interaction
CEP135CPAPintact, string_interaction
CEP135MCPH1string_interaction
CEP135MFSD2Astring_interaction
CEP135SASS6intact, string_interaction
CEP135STILstring_interaction
CEP135WDR62string_interaction
CEP135ZNF335string_interaction
CEP152CEP63biogrid_interaction, string_interaction
CEP152CPAPstring_interaction
CEP152MCPH1string_interaction
CEP152SASS6biogrid_interaction, string_interaction
CEP152STILstring_interaction
CEP152TRAPPC14string_interaction
CEP152WDR62intact, string_interaction
CEP152ZNF335string_interaction
CEP63CPAPstring_interaction
CEP63SASS6string_interaction
CEP63STILstring_interaction
CEP63WDR62string_interaction
CITKIF14string_interaction

Structural data

PDB: 18 · AlphaFold-only: 8 · No structure: 1

Cohort genes with PDB structures (top 30)

SymbolUniProtPDB entries
TAF13Q1554328
CDK6Q0053422
MCPH1Q8NEM09
KNL1Q8NG317
ANGPT2O151237
CPAPQ9HC776
STILQ154685
CDK5RAP2Q96SN84
METTL5Q9NRN93
CEP63Q96MT83
CEP152O949863
COPB2P356062
SASS6Q6UVJ02
CEP135Q66GS92
PYCR2Q96C362
MFSD2AQ8NA291
NCAPD3P426951
PHC1P783641

AlphaFold-only cohort genes (top 30 by pLDDT)

SymbolUniProtpLDDT
TRAPPC14Q8WVR371.53
CITO1457869.75
KIF14Q1505865.68
ANKLE2Q86XL365.14
TEDC1Q86SX363.08
WDR62O4337961.19
ZNF335Q9H4Z252.13
ASPMQ8IZT6

Function

Pathway analysis

Distinct Reactome pathways touched by cohort: 108. Enrichment computed across 27 evidence-associated genes (19 with Reactome annotation).

Pathways by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 19 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

PathwayCohort genesFoldFDRSample cohort genes
Loss of Nlp from mitotic centrosomes541.7×4e-06CPAP, CDK5RAP2, CEP63, CEP135, CEP152
Loss of proteins required for interphase microtubule organization from the centrosome541.7×4e-06CPAP, CDK5RAP2, CEP63, CEP135, CEP152
AURKA Activation by TPX2540.1×4e-06CPAP, CDK5RAP2, CEP63, CEP135, CEP152
Recruitment of mitotic centrosome proteins and complexes535.8×6e-06CPAP, CDK5RAP2, CEP63, CEP135, CEP152
Regulation of PLK1 Activity at G2/M Transition533.4×6e-06CPAP, CDK5RAP2, CEP63, CEP135, CEP152
Recruitment of NuMA to mitotic centrosomes530.7×8e-06CPAP, CDK5RAP2, CEP63, CEP135, CEP152
Anchoring of the basal body to the plasma membrane529.8×8e-06CPAP, CDK5RAP2, CEP63, CEP135, CEP152
Cell Cycle, Mitotic615.2×2e-05MCPH1, CDK6, KNL1, CEP63, ANKLE2, CEP152
M Phase517.4×9e-05MCPH1, KNL1, CEP63, ANKLE2, CEP152
Cell Cycle611.4×9e-05MCPH1, CDK6, KNL1, CEP63, ANKLE2, CEP152
RHO GTPases activate CIT263.3×0.004CIT, KIF14
Centrosome maturation226.7×0.021CEP63, CEP152
Mitotic Prometaphase310.9×0.021KNL1, CEP63, CEP152
Diseases of Cellular Senescence1200.3×0.028CDK6
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects1200.3×0.028CDK6
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK61200.3×0.028CDK6
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects1200.3×0.028CDK6
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK61200.3×0.028CDK6
Diseases of cellular response to stress1200.3×0.028CDK6
Condensation of Prophase Chromosomes216.5×0.035MCPH1, NCAPD3
Drug-mediated inhibition of CDK4/CDK6 activity1120.2×0.043CDK6
Mitotic G2-G2/M phases213.4×0.045CEP63, CEP152
G2/M Transition213.4×0.045CEP63, CEP152
Cilium Assembly211.4×0.058CEP63, CEP152
Mitotic Metaphase and Anaphase210.2×0.067KNL1, ANKLE2
Mitotic Anaphase210.2×0.067KNL1, ANKLE2
Signaling by Rho GTPases35.4×0.068KIF14, KNL1, ANKLE2
Oxidative Stress Induced Senescence29.5×0.068CDK6, PHC1
Signaling by Rho GTPases, Miro GTPases and RHOBTB335.3×0.068KIF14, KNL1, ANKLE2
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects146.2×0.077CDK6

GO biological processes by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 26 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

GO termCohort genesFoldFDRSample cohort genes
centriole replication7197.3×5e-13CPAP, WDR62, CDK5RAP2, SASS6, CEP63, CEP135, CEP152
positive regulation of centriole replication3388.9×4e-06CPAP, STIL, SASS6
positive regulation of spindle assembly3243.1×1e-05CPAP, STIL, SASS6
cell division712.4×6e-05CPAP, CDK6, KIF14, KNL1, CEP63, NCAPD3, ANKLE2
centrosome duplication3108.0×1e-04STIL, SASS6, CEP152
regulation of mitotic spindle organization397.2×1e-04CPAP, STIL, SASS6
cerebral cortex development431.6×2e-04ASPM, WDR62, MCPH1, KIF14
positive regulation of neuroblast proliferation367.0×3e-04ASPM, WDR62, ZNF335
de novo centriole assembly involved in multi-ciliated epithelial cell differentiation2259.3×6e-04CEP63, CEP152
positive regulation of establishment of protein localization2216.1×8e-04CPAP, CEP135
positive regulation of G1/S transition of mitotic cell cycle346.3×8e-04CPAP, STIL, SASS6
regulation of mitotic cell cycle spindle assembly checkpoint2162.0×0.001CDK5RAP2, KNL1
regulation of centrosome cycle2144.0×0.001WDR62, MCPH1
positive regulation of non-motile cilium assembly2144.0×0.001CPAP, CEP135
regulation of centriole replication2129.6×0.002CPAP, STIL
generation of neurons2117.8×0.002CIT, CDK6
microtubule organizing center organization2108.0×0.002STIL, CDK5RAP2
regulation of G2/M transition of mitotic cell cycle299.7×0.002CDK6, KIF14
regulation of neuron differentiation256.4×0.007WDR62, CDK5RAP2
protein localization to centrosome251.9×0.007MCPH1, STIL
neuronal stem cell population maintenance251.9×0.007ASPM, MCPH1
cerebellar granular layer structural organization1648.1×0.012KIF14
astral microtubule nucleation1648.1×0.012CPAP
negative regulation of asymmetric cell division1648.1×0.012ASPM
negative regulation of positive chemotaxis1648.1×0.012ANGPT2
lysophospholipid translocation1648.1×0.012MFSD2A
regulation of phosphatidylethanolamine metabolic process1648.1×0.012MFSD2A
obsolete regulation of phosphatidylserine metabolic process1648.1×0.012MFSD2A
regulation of cell maturation1648.1×0.012KIF14
positive regulation of meiosis I spindle assembly checkpoint1648.1×0.012KNL1

Therapeutics

Drug target analysis

Approved (phase 4): 2 · Phase ≥3: 2 · Phased (≥1): 3 · Undrugged: 24

Druggability breadth: 8 of 27 evidence-associated genes (30%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).

Genes with an approved drug

The molecule shown is one approved compound that hits the gene — not necessarily a drug of choice or one indicated for this disease.

SymbolExample approved molecule
CITMOMELOTINIB
CDK6PALBOCICLIB

Top cohort targets by molecule count

SymbolMoleculesMax phase
CDK6454
CIT414
NCAPD312
TAF1300
CPAP00
ASPM00
WDR6200
MCPH100
STIL00
CDK5RAP200

Drugs targeting cohort genes (top 30)

MoleculeMax phaseTargets in cohort
MOMELOTINIB4CDK6, CIT
AFATINIB4CIT
FEDRATINIB4CIT
SORAFENIB4CDK6, CIT
RUXOLITINIB4CIT
BARICITINIB4CIT
VANDETANIB4CIT
BOSUTINIB4CIT
ABEMACICLIB4CDK6, CIT
GILTERITINIB4CIT
SUNITINIB4CIT
ERLOTINIB4CIT
GEFITINIB4CIT
PALBOCICLIB4CDK6
RIBOCICLIB4CDK6
TRILACICLIB4CDK6
DABRAFENIB4CDK6
OLAPARIB4CDK6
VATALANIB3CIT
AFURESERTIB3CIT
CANERTINIB3CIT
FASUDIL3CIT
ALVOCIDIB3CDK6, CIT
DOVITINIB3CDK6, CIT
MOTESANIB3CIT
LESTAURTINIB3CDK6, CIT
RUBOXISTAURIN3CIT
LEROCICLIB3CDK6
DINACICLIB3CDK6
DALPICICLIB3CDK6

Bioactivity and enzyme data

Enzyme cohort genes (≥1 EC): 1.

Cohort genes with ChEMBL bioactivity (full, sorted by assay count)

SymbolAssaysType breakdown
CDK6715Binding:691, Functional:24
CIT145Binding:145
NCAPD36Binding:6
PYCR22Binding:2
KIF141Binding:1
COPB21Binding:1
METTL51Binding:1

Cohort enzymes (BRENDA EC)

SymbolEC numbersNames
CDK62.7.11.22cyclin-dependent kinase

Cohort genes with high screening signal

≥100 ChEMBL assays — a studied-ness signal; see Therapeutics for approved-drug status.

SymbolChEMBL assays
CIT145
CDK6715

Pharmacogenomics

Cohort genes with a PharmGKB record: 26; with CPIC/DPWG dosing guidelines: 0.

No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).

Chemical tractability of cohort targets

30 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.

CompoundMax phaseCohort target (bioactivity)
MOMELOTINIB4CDK6, CIT
AFATINIB4CIT
FEDRATINIB4CIT
SORAFENIB4CDK6, CIT
RUXOLITINIB4CIT
BARICITINIB4CIT
VANDETANIB4CIT
BOSUTINIB4CIT
ABEMACICLIB4CDK6, CIT
GILTERITINIB4CIT
SUNITINIB4CIT
ERLOTINIB4CIT
GEFITINIB4CIT
PALBOCICLIB4CDK6
RIBOCICLIB4CDK6
TRILACICLIB4CDK6
DABRAFENIB4CDK6
OLAPARIB4CDK6
VATALANIB3CIT
AFURESERTIB3CIT
CANERTINIB3CIT
FASUDIL3CIT
ALVOCIDIB3CDK6, CIT
DOVITINIB3CDK6, CIT
MOTESANIB3CIT
LESTAURTINIB3CDK6, CIT
RUBOXISTAURIN3CIT
LEROCICLIB3CDK6
DINACICLIB3CDK6
DALPICICLIB3CDK6

Druggability pyramid

Cohort genes binned by druggability tier (high → low):

TierDefinitionGenesSymbols
AApproved (phase 4 drug)2CIT, CDK6
BPhased (≥1) drug, not yet approved1NCAPD3
CDruggable family + PDB, no drug1MFSD2A
DDruggable family + AlphaFold only, no drug1ASPM
EDifficult family or no structure, no drug22TAF13, CPAP, WDR62, MCPH1, STIL, CDK5RAP2, KIF14, TEDC1, COPB2, KNL1 (+12 more)

Undrugged target profiles

24 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).

SymbolChEMBL assaysDrugged partners (top 3)
KIF141CIT
TAF130
CPAP0
ASPM0
WDR620
MCPH10
STIL0
CDK5RAP20
TEDC10
COPB21
KNL10
METTL51
SASS60
TRAPPC140
CEP630
MFSD2A0
CEP1350
ANKLE20
CEP1520
PYCR22
PHC10
ZNF3350
ANGPT20
MCPH1-AS10

Clinical trials & evidence

Clinical trials

Clinical trials: 0.